Angel David Osorio-Pena
Overview
Explore the profile of Angel David Osorio-Pena including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
19
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mendoza-Pinto C, Etchegaray-Morales I, Munguia-Realpozo P, Rojas-Villarraga A, Osorio-Pena A, Mendez-Martinez S, et al.
J Clin Rheumatol
. 2023 Oct;
30(1):1-7.
PMID: 37798834
Objective: To describe the results from the Global Burden Disease (GBD) study 2019 on the burden of other musculoskeletal (MSK) disorders in Latin America and the Caribbean (LAC). Methods: In...
2.
Mendoza-Pinto C, Etchegaray-Morales I, Munguia-Realpozo P, Solis-Poblano J, Osorio-Pena A, Zarate-Arellano D, et al.
Clin Rheumatol
. 2023 Sep;
43(1):1-13.
PMID: 37775642
Objective: This study aimed to describe the disease burden and trends of musculoskeletal (MSK) disorders in Mexico from 1990 to 2019. Method: A cross-sectional study using systematic analysis from the...
3.
Mendoza-Pinto C, Etchegaray-Morales I, Munguia-Realpozo P, Osorio-Pena A, Mendez-Martinez S, Ramirez-Lara E, et al.
Lupus
. 2023 Sep;
32(11):1328-1334.
PMID: 37705367
Background: Low disease activity state (LDAS) has been linked to a significant reduction in flares and damage accrual in patients with systemic lupus erythematosus (SLE); however, the effect of LDAS...
4.
Munguia-Realpozo P, Mendoza-Pinto C, Etchegaray-Morales I, Osorio-Pena A, Velez-Pelcastre S, Escamilla-Marquez M, et al.
Horm Metab Res
. 2023 May;
55(7):487-492.
PMID: 37178683
The aims of this study were in systemic lupus erythematosus (SLE) patients: 1) to compare the metabolomic profile of insulin resistance (IR) with controls and 2) to correlate the metabolomic...
5.
Munguia-Realpozo P, Etchegaray-Morales I, Mendoza-Pinto C, Mendez-Martinez S, Osorio-Pena A, Ayon-Aguilar J, et al.
Autoimmun Rev
. 2023 Feb;
22(5):103294.
PMID: 36791873
Objective: We carried out a systematic review (SR) of adherence in diagnostic and prognostic applications of ML in SLE using the Transparent Reporting of a multivariable prediction model for Individual...
6.
Mendoza-Pinto C, Etchegaray-Morales I, Munguia-Realpozo P, Solis-Poblano J, Mendez-Martinez S, Osorio-Pena A, et al.
Lupus
. 2022 Sep;
31(13):1679-1684.
PMID: 36128770
Background: Hospitalizations due to systemic lupus erythematosus (SLE) incur substantial resource use. Hospitalization trends provide a key benchmark of the disease burden. However, there is little long-term data in Mexico....
7.
Garcia-Carrasco M, Mendoza-Pinto C, Etchegaray-Morales I, Munguia-Realpozo P, Osorio-Pena A, Navarro-Milan O, et al.
Arch Med Res
. 2022 Aug;
53(6):610-616.
PMID: 36038446
Objective: To investigate national temporal trends over time in mortality rates in patients with systemic sclerosis (SSc) in Mexico between 1998 and 2017. Methods: Deaths between 1998 and 2017 were...
8.
Etchegaray-Morales I, Mendoza-Pinto C, Munguia-Realpozo P, Osorio-Pena A, Ibanez-Ovando S, Pineda C, et al.
Rheumatol Int
. 2022 Jun;
42(10):1715-1720.
PMID: 35674740
Systemic lupus erythematosus (SLE) is one of the leading causes of death in younger adults, but advances in diagnosis and management during recent years may have reduced mortality. We examined...
9.
Mendoza-Pinto C, Etchegaray-Morales I, Garcia-Carrasco M, Munguia-Realpozo P, Mendez-Martinez S, Osorio-Pena A, et al.
Lupus
. 2022 Feb;
31(3):382-391.
PMID: 35188438
Objective: Regional variations in systemic lupus erythematosus (SLE) mortality may be due to different spectra of local environmental factors. The aim of this study was to assess mortality trends in...
10.
Etchegaray-Morales I, Jimenez-Herrera E, Mendoza-Pinto C, Rojas-Villarraga A, Macias-Diaz S, Osorio-Pena A, et al.
J Transl Autoimmun
. 2021 Nov;
4:100135.
PMID: 34825158
is a gram-negative bacterium that adapts to the gastric mucosa and provokes symptoms associated with gastritis. Chronic infection in patients with a genetic predisposition can trigger autoimmune diseases due to...